Diploma (LON:DPLM) Trading Up 17.8% on Analyst Upgrade

Diploma PLC (LON:DPLM) shares were up 17.8% on Thursday after Berenberg Bank raised their price target on the stock from GBX 6,600 to GBX 7,500. Berenberg Bank currently has a buy rating on the stock. Diploma traded as high as GBX 6,019.52 and last traded at GBX 5,925. Approximately 2,896,099 shares changed hands during mid-day trading, an increase of 68% from the average daily volume of 1,720,148 shares. The stock had previously closed at GBX 5,030.

A number of other brokerages have also recently weighed in on DPLM. Shore Capital Group reissued a “hold” rating on shares of Diploma in a research report on Wednesday. Royal Bank Of Canada increased their target price on Diploma from GBX 6,200 to GBX 6,600 and gave the company an “outperform” rating in a research note on Thursday. Peel Hunt reiterated a “buy” rating and set a GBX 6,150 target price on shares of Diploma in a report on Friday, December 19th. Stifel Nicolaus boosted their price target on Diploma from GBX 6,200 to GBX 6,800 and gave the stock a “buy” rating in a research report on Thursday. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of Diploma from GBX 6,200 to GBX 6,400 and gave the company a “buy” rating in a research report on Thursday. Five research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of GBX 6,023.75.

Insider Buying and Selling

In related news, insider Johnny Thomson sold 30,000 shares of Diploma stock in a transaction dated Friday, January 16th. The shares were sold at an average price of GBX 5,668, for a total value of £1,700,400. Also, insider Ian El-Mokadem bought 500 shares of Diploma stock in a transaction on Wednesday, January 14th. The shares were purchased at an average cost of GBX 5,615 per share, with a total value of £28,075. Company insiders own 1.14% of the company’s stock.

Key Headlines Impacting Diploma

Here are the key news stories impacting Diploma this week:

• Positive Sentiment: Surprise profit upgrade forced a re‑rating of consensus and sparked a ~17% share jump as investors digested stronger-than-expected guidance. Diploma shares surge 17% as surprise profit upgrade exposes the bearish consensus
• Positive Sentiment: Guidance upgrade lifted Diploma’s earnings forecasts (~15%) and prompted price-target increases (headline 6,600p), reinforcing the bullish re-rate. Diploma price target lifted to 6,600p after guidance upgrade drives 15% earnings forecast rise
• Positive Sentiment: Berenberg raised its price target sharply to GBX 7,500 and moved to a “buy” rating, signaling confidence in the upgraded outlook. Broker ratings
• Positive Sentiment: Stifel increased its target to GBX 6,800 and upgraded to “buy”, adding to the cluster of upward revisions from brokers. Broker ratings
• Positive Sentiment: Deutsche Bank raised its target to GBX 6,400 and now carries a “buy” stance, supporting the upward momentum. Broker ratings
• Positive Sentiment: Royal Bank of Canada lifted its target to GBX 6,600 and set an “outperform” rating — another well‑known house backing the upgraded story. RBC note
• Negative Sentiment: Shore Capital reaffirmed a “hold” rating on 20 March, which may have damped some of the rally and encouraged profit‑taking after the sharp run. Shore Capital Group Reaffirms Hold Rating for Diploma

Diploma Stock Performance

The firm’s fifty day simple moving average is GBX 5,457.51 and its 200 day simple moving average is GBX 5,425.55. The company has a debt-to-equity ratio of 46.97, a current ratio of 2.04 and a quick ratio of 0.80. The company has a market capitalization of £7.66 billion, a price-to-earnings ratio of 41.61, a PEG ratio of 2.82 and a beta of 1.03.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.